Benitec Biopharma LTD ADR reports a Return on Equity (ROE) of -26.66%.

What is BNTC's dividend yield?

Benitec Biopharma LTD ADR offers a dividend yield of 0.00%.

What is BNTC's Quality Score?

Our AI rates BNTC's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BNTC?

Our AI Timing Score for BNTC is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BNTC belong to?

Benitec Biopharma LTD ADR is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Benitec Biopharma LTD ADR (BNTC) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

BNTC AI Analysis Summary

Our AI summary for BNTC: Benitec Biopharma LTD ADR (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -26.66%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 70/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

BNTC

Benitec Biopharma LTD ADR

US:NASDAQ STOCK Healthcare >> Biotechnology News 94

USD 12.52

0.37 (3.05%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-26.7%

ROE

-26.1%

ROA

0.00%

Div Yield

BENITEC BIOPHARMA LTD ADR
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 12.52 Price 0.37 (3.05%) Day Change	NEWS SCORE: 94

BNTC, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	12.52
PBV / Sector	2.28 / 44,022.72
Earning Per Share	-1.47

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	0.95 M GREAT
Average 1W Daily Value	0.89 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-8,792.09 / 98.24
NPM Average (%) / Sector	-17,471.78 / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-26.14 / 185,260.96
ROA Average (%) / Sector	-169.79 / 36,684.70
ROA Change Average (%) / Sector	-21.67 / 422,221.66
ROE (%) / Sector	-26.66 / 243,762.23
ROE Average (%) / Sector	-2,085.52 / 48,758.47
ROE Change Average (%) / Sector	321.59 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 07:59:55
Symbol	BNTC
Name	BENITEC BIOPHARMA LTD ADR
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	34.35 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	417.41 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 3940 Trust Way, Hayward, CA, United States, 94545

Phone: 510 780 0819

Website: https://benitec.com

Sector: Healthcare >> Biotechnology

Description: Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.